Edesa Biotech Inc buy Brookline Capital Management
Start price
12.10.23
/
50%
€0.39
Target price
12.10.24
€54.12
Performance (%)
0.00%
Price
20.11.23
€0.39
Summary
This prediction is currently active. Brookline_Capital_Ma's BUY prediction for Edesa Biotech Inc is currently unchanged. This prediction currently runs until 12.10.24. The prediction end date can be changed by Brookline_Capital_Ma at any time. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edesa Biotech Inc | - | - |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Edesa Biotech Inc diskutieren
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $57.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat